Johnson & Johnson is recalling five of its sunscreen products after some samples were found to contain low levels of benzene, a chemical that can cause cancer with repeated exposure.

Johnson & Johnson recalls several aerosol sunscreen products after detecting cancer-causing agent

Brazilian federal prosecutors have opened an investigation into a contract worth 1.6 billion reais ($320 million) for 20 million doses of a COVID-19 vaccine made by India's Bharat Biotech, according to a document seen by Reuters on Tuesday.

Brazil prosecutors probe price, intermediary on Bharat Biotech vaccine deal

The US Food and Drug Administration (FDA) has reported that nearly 60 million doses of the Johnson & Johnson coronavirus vaccine have been disposed off due to possible contamination.

Germany demands replacement of 60 million contaminated J&J vaccine doses

A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published Sunday.

European Medicines Agency official suggests ditching AstraZeneca jab

South Africa, which is struggling to roll out its inoculation programme as it enters a third wave of the coronavirus pandemic, said Sunday it will pull two million doses of the Johnson & Johnson vaccine following contamination concerns at one of the US drugmaker's sites.

South Africa pulls two million doses of Johnson & Johnson vaccine

US’ Food and Drug Administration (FDA) has increased the shelf life of the Johnson & Johnson coronavirus vaccine from three to four-and-a-half months. This has come as a piece of good news as millions of doses stored in clinical refrigerators around the world faced the danger of expiring and experts feared they might have to toss out the existing doses.

US: FDA extends shelf-life of J&J vaccine from 3 to 4.5 months

Scientists in Germany are claiming to have solved the mystery behind blood clots from AstraZeneca and J&J vaccines. The study says spliced spike proteins may be responsible for the rare side effect. Palki Sharma gets you a report.

Gravitas: Scientists claim to have solved the blood clot puzzle

UK on Friday approved the single-shot Covid vaccine developed by Johnson & Johnson, as per the announcement by the Medicines and Healthcare products Regulatory Agency (MHRA).

UK approves single shot Johnson & Johnson coronavirus vaccine

The coronavirus vaccine developed by AstraZeneca has faced criticism as some people developed ‘blood clots’ after getting jabbed. However, a group of German scientists has found a way to avoid the deadly side effect.

Vaccines can be redesigned to avoid blood clots, German scientists claim

German researchers on Wednesday said that based on laboratory research they have found the cause of rare but serious blood clotting events among some people who have received COVID-19 vaccine made by AstraZeneca and Johnson & Johnson.

German researchers claimed to have found cause of blood clotting events

India's Biological E. will produce the Johnson & Johnson COVID-19 vaccine alongside its own candidate, its managing director told Reuters on Tuesday, which could boost the country's overall supplies amid a shortage.

India's Biological E. to produce J&J COVID-19 vaccine

The US is eyeing joint production of the Johnson & Johnson coronavirus vaccine with India, aiming to ramp up production of the jabs. US chargé d’affaires Daniel Smith has revealed that the US government is in talks with its Indian counterpart to arrange the raw materials — listed by India — needed to manufacture the vaccines.

US mulls joint production of Johnson & Johnson Covid vaccine with India

Germany has decided to uplift its prioritization on restrictions on the usage of Johnson & Johnson COVID-19 vaccine. J&J jab will be available for all adults for widespread use across the country. The roll-out of the J&J vaccine had been delayed in Germany and other countries in Europe due to blood clot concerns.

J&J COVID-19 vaccine ready for widespread use in Germany

A Canadian government advisory panel on Monday recommended the use of the Johnson & Johnson vaccine for people aged 30 years and over, despite blood clotting fears. Shelley Deeks of the National Advisory Committee on Immunization (NACI) said the J&J jab has proven to be 'highly effective' in preventing severe COVID-19 infections and hospitalizations.

Canada recommends J&J jab for 30 years and over, despite blood clot fears

For Poles, the May long weekend is usually a time for grilling, socializing and drinking. But in the middle of a pandemic, there is no normal life. So thousands across Poland stood in pouring rain, waiting in line to get a Johnson & Johnson COVID-19 jab instead.

Thousand across Poland stood in the pouring rain for J&J COVID-19 jab

Denmark said Monday it would not include the Covid-19 vaccine from US drugmaker Johnson & Johnson in its national vaccination campaign, citing worries over serious side effects involving blood clots.

Denmark drops Johnson & Johnson from Covid vaccination programme

US health regulators said on Friday that use of Johnson & Johnson Covid vaccine could restart. The rollout of the vaccine was paused due to worries over blood clotting.

US regulators approve restarting use of Johnson & Johnson Covid vaccine

Denmark's health authority said on Wednesday it expects to announce its decision on how to proceed with Johnson & Johnson's COVID-19 vaccine next week pending f

Denmark to decide on Johnson & Johnson COVID-19 shot next week

Europe's drug regulator was expected to rule on Tuesday on the safety of the Johnson & Johnson Covid-19 vaccine after fears it could be linked to extremely rare blood clots, while India said it will make shots available to all adults as it battles a terrifying wave of infections.

EU to rule on Johnson & Johnson vaccine’s safety  

The European Medicines Agency will be announcing its decision on the Johnson & Johnson COVID-19 vaccine usage today.

Coronavirus Vaccine: Johnson & Johnson rollout suspended in United States

The EU will not renew COVID-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson.

Report: EU to end AstraZeneca, J&J contracts at expiry

Europe’s medical regulator, the European Medicines Agency, has said it will announce a decision on the safety of Johnson & Johnson’s coronavirus vaccine on Tuesday.

Europe's EMA to take final decision on J&J coronavirus vaccine on Tuesday

According to the reports, EU Commission has decided not to renew COVID-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson (J&J).

Report: EU to end AstraZeneca and J&J vaccine contracts at expiry

The Centers for Disease Control and Prevention has decided to extend the pause imposed on emergency use of the Johnson & Johnson (J&J) vaccine in the US as the researchers felt there is a lack of data on the rare blood clotting side effect.

US continues pause on Johnson & Johnson vaccine over reports of blood clots

johnson-johnson

Johnson & Johnson, News on Johnson & Johnson, stories on Johnson & Johnson, articles on Johnson & Johnson, Johnson & Johnson stories at Wion, Johnson & Johnson news, Johnson & Johnson latest news

johnson johnson